【レポートの概要(一部)】
1. Report Overview
1.1 Global Generic Drugs: Market Overview
1.2 Global Generic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. An Introduction to Generic Drugs
2.1 An Introduction to the Rise of Generic Drugs
2.2 What Are Generic Drugs?
2.2.1 Generic Active Ingredients
2.3 A Brief Overview of the Pharmaceutical Industry
2.3.1 Brief History of Generic Drugs
2.3.2 The Hatch-Waxman Act: The Rise of Generics
2.4 Demonstrating Bioequivalence: A Major Factor in Approving Generics
2.5 Types of Generics – Authorised, Branded and Unbranded
2.6 Complex Generics
2.7 Classification of Generic Drugs Markets
2.8 Is Generic Substitution Bad News for Big Pharma Business?
2.8.1 The ‘Evergreening’ of Pharmaceutical Products
2.9 Regulation of Generic Drugs
2.9.1 Regulation in the US
2.9.2 Regulation in Europe
2.9.3 Regulation in Japan
2.9.4 Regulation in China
2.10 Compulsory Licensing
2.11 Market Definition and Scope of This Report
2.11.1 Market Sizing and Revenue Reporting
2.11.2 Currency Exchange Rates in This Report
3. Generic Drugs Market 2016-2026
3.1 The Global Generic Drugs Market: Market Overview
3.1.1 Segmenting the Global Generic Drugs Market
3.2 The Rise of the Global Generic Drugs Market in 2015
3.3 Changes in the Regional Distribution of the Generic Drugs Market 2014-2015
3.4 The Global Generic Drugs Market: Sales Forecast 2016-2026
3.5 Generic Drugs: Regional Market Forecast: 2016-2026
3.5.1 Changes in Generic Drug Regional Market Shares 2016-2026
3.6 Leading National Markets for Generic Drugs: Market Forecast 2016-2026
3.7 National Markets that will Drive Generic Drugs Growth
3.8 Changes in Market Shares by National Market 2016-2026
3.9 Drivers and Restraints for the Global Generic Drugs Market 2016-2026
4. US Generic Drugs Market, 2016-2026
4.1 Generic Drugs in the US: Market Overview
4.1.1 The Effects of Generics on Healthcare Spending in the US
4.1.2 The Hatch-Waxman Act and Its Ongoing Effects
4.1.3 Consolidation in the Drug Development and Supply Chain Driving US Generics
4.2 US Historical Generic Penetration Rates
4.3 Leading Companies Operating within the US Generic Drugs Market
4.3.1 The Increasing Acceptance of Generics amongst Consumers
4.3.2 Affordable Care Act: Expanding Medicare Coverage
4.4 The US Generic Drugs Market: Drivers and Restraints 2016-2026
4.5 The US Generic Drugs Market Forecast: 2016-2026
4.6 The US Generic Drugs Market – Strategic Analysis
4.6.1 Will Biosimilars Dictate the Future of the US Generics Market?
4.6.2 The Backlog of ANDA Applications
4.6.3 The Generic Drug User Fee Amendments (GDUFA)
4.6.4 Shortages of Generic Drugs Will Restrain the Market
4.6.5 The Anti-Competitive ‘Pay for Delay’ Effect
4.7 US Generic Drugs Market: A Range of Factors Contributing to Growth
5. Leading European Generic Drug Market, 2016-2026
5.1 European Generic Drugs: Market Overview
5.1.1 The EU5
5.1.2 Why Growth in Some Markets is Being Hindered?
5.1.3 Predominant Pricing Systems and Generic Penetration In European Markets
5.1.4 Will Europe Move towards Free-Pricing Systems?
5.1.5 Challenges in the European Regulatory Environment
5.1.6 Ending Anti-Competitive ‘Pay for Delay’ Tactics in Europe
5.1.7 FDA and EMA Joint Data Sharing and Inspections
5.2 EU5 Generic Drugs Market Forecast: 2016-2026
5.3 EU5 Market Share Breakdown 2016-2026
5.4 Germany: New Reforms to Medicinal Pricing May Impact Market Entry
5.4.1 German Generic Drugs Market: Generic Penetration By Volume, 2000-2015
5.4.2 German Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5 UK Generic Drugs Market: A Mature Market with Growth Potentials
5.5.1 UK Generic Drugs Market: Sales Forecast 2016-2026
5.5.2 Cost Pressures and Demand-Side Policies Drive UK Generic Penetration
5.5.3 UK Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.5.4 UK Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5.5 Pharmacists as Enforcers of Generic Substitution
5.5.6 Pay Time for ‘Pay-For-Delay’
5.5.7 GSK: Widening the Gate to Accessible Medicines
5.6 French Generic Drugs Market: Healthcare Reforms Impacting on Market Growth
5.6.1 French Generic Drugs Market: Sales Forecast 2016-2026
5.6.2 French Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.6.3 French Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.7 Italian Generic Drugs Market: Branded Generics Hindering Overall Growth
5.7.1 The Tightening of Italy’s Patent Legislations
5.7.2 The Italian Healthcare System – A Tale of Falling Budgets
5.7.3 Italian Generic Drugs Market: Sales Forecast: 2016-2026
5.7.4 Italian Generic Drugs market: Generic Penetration by Volume
5.7.5 Italian Generic Drugs Market: Generic Penetration by Value
5.8 Spain
5.8.1 Cost-Containment Measures Helping to Boost Generic Drug Use
5.8.2 Spanish Generic Drugs Market: Sales Forecast 2016-2026
5.8.3 Spanish Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.8.4 Spanish Generic Drugs Market: Generic Penetration by Value, 2000-2015
6. Asia-Pacific Generic Drugs Market, 2016-2026
6.1 Generic Drugs in the Asia-Pacific Market: Market Overview
6.2 Chinese Generic Drugs Market: Domestic Companies Dominate the Market Landscape
6.2.1 The Major Drivers of Growth in the Chinese Generics Market
6.2.2 Chinese Generic Drugs Market: Sales Forecast 2016-2026
6.2.3 Compulsory Licensing of Generic Drugs
6.2.4 Expansion of Healthcare Coverage and Reimbursement
6.2.5 Chinese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.2.6 Chinese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.2.7 The Impacts of Price Controls and the Anhui Model
6.3 Japanese Generic Drugs Market: High Barriers to Entry
6.3.1 Public Perception of Generics in Japan
6.3.2 Japanese Generic Drugs Market: Leading Companies
6.3.3 Japanese Generic Drugs Market: Sales Forecast 2016-2026
6.3.4 Japanese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.3.5 Japanese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.3.6 Government Initiatives Driving Generic Penetration
6.3.7 Japanese Attitudes to Generic Drugs
6.4 Indian Generic Drugs Market: Regulatory Failures Hindering Sales Growth
6.4.1 Leading Companies in the Indian Generic Drugs Market
6.4.2 Indian Generic Drugs Market: Sales Forecast 2016-2026
6.4.3 The Reforms to India’s Drug Prices Control Order and Its Likely Effects on Generic Drugs Revenues
6.4.4 Expansion of the National Healthcare Coverage Increases the Need for Generics
6.4.5 Has Recent Manufacturing Quality Failures Dented India’s Generics Growth?
7. Emerging Generic Drugs Market, 2016-2026
7.1 Generic Drugs in the Emerging Market: Market Overview
7.1.1 Emerging Economies: Improving Logistics and Better Infrastructure Catalysing Generics Growth
7.2 Brazil
7.2.1 Brazilian Generic Drugs Market: Sales Forecast 2016-2026
7.2.2 Generics to Facilitate Low-Income Earner’s Access to Medicines
7.2.3 Foreign Generic Drug Manufacturers Entering the Brazilian Market
7.3 Russian Generic Drugs Market: Improving IP Protection to Aid Market Growth
7.3.1 Historical Trends in Russia’s Pharmaceutical Production and Distribution
7.3.2 The Pharma2020 Strategy – Healthcare and Industry Reform
7.3.3 Self-Medication in Russia and the Integral Role of Pharmacies
7.3.4 Russian Generic Drugs Market: Sales Forecast 2016-2026
7.4 Mexico
7.4.1 Government Programmes to Vitalise Generic Penetration in Mexico
7.4.2 Regulatory Changes and the Inception of COFEPRIS
7.4.3 Mexican Generic Drugs Market: Sales Forecast 2016-2026
7.5 South Korea
7.5.1 Pharmaceutical Price Controls and Measures Being Implemented in South Korea
7.5.2 South Korean Generic Drugs Market: Sales Forecast 2016-2026
7.6 Turkey
7.6.1 Cost Cutting Measures and their Effects on Turkish Generics
7.6.2 Will Turkey Become a Production Base for High Technology Products?
7.6.3 Turkish Generic Drugs Market: Sales Forecast 2016-2026
7.6.4 Regulatory Guidelines for Generic Drugs in Turkey
7.6.5 How Effective has Turkey’s Health Transformation Programme Been?
8. Leading Companies in the Generic Drugs market, 2016-2026
8.1 Generic Drugs: Continuous Expansion to Rival
8.1.1 The Leading Companies in the Global Generics Market
8.2 Teva
8.2.1 Teva: Historical Financial and Performance Analysis, 2010-2014
8.2.2 Teva Generic Drugs Sales Forecast 2016-2026
8.2.3 Teva and Allergan Spin-Off Generic Drug Deal
8.2.4 Allergan: Historical Financial and Performance Analysis, 2010-2014
8.2.5 Allergan: Developments in Generic Drug Segment Prior Mega-Deal
8.2.6 Teva: Generic Drugs Portfolio Analysis, 2016
8.2.7 Teva: What Future Moves Could We Expect?
8.3 Novartis
8.3.1 Novartis: Historical Financial and Performance Analysis, 2010-2014
8.3.2 Novartis Generic Drugs Sales Forecast 2016-2026
8.3.3 Novartis Generic Drugs Portfolio Analysis, 2016
8.3.4 What Does the Future Hold for Novartis’ Generic Drugs Business?
8.4 Mylan
8.4.1 Mylan: Historical Financial and Performance Analysis, 2010-2014
8.4.2 Mylan Generic Drugs Sales Forecast 2016-2026
8.4.3 Mylan: Recent Developments
8.4.4 Mylan’s Collaborative Efforts
8.4.5 What Does the Future Hold for Mylan’s Generic Drugs Business?
8.5 Pfizer
8.5.1 Pfizer: Historical Financial and Performance Analysis, 2010-2014
8.5.2 Pfizer’s Restructuring Strategy
8.5.3 Pfizer’s Done Deal with Hospira
8.5.4 Pfizer Generic Drugs Sales Forecast 2016-2026
8.5.5 Hospira: A Brief Overview of Operations
8.5.6 Hospira: Historical Financial and Performance Analysis 2010-2014
8.5.7 Hospira: Recent Developments
8.5.8 Future Prospects for Pfizer’s Generic Business
8.6 Abbott
8.6.1 Abbott: Historical Financial and Performance Analysis, 2010-2014
8.6.2 Abbott Generic Drugs Sales Forecast 2016-2026
8.6.3 Abbott: Recent Developments
8.6.4 What Does the Future Hold for Abbott’s Generic Drugs Business?
8.7 Sun Pharma
8.7.1 Sun Pharma’s Business Areas
8.7.2 Sun Pharma: Historical Financial and Performance Analysis, 2010-2014
8.7.3 Sun Pharma Generic Drugs Sales Forecast 2016-2026
8.7.4 Sun Pharma-Ranbaxy Acquisition
8.8 Aspen
8.8.1 Aspen: Historical Financial and Performance Analysis, 2010-2014
8.8.2 Aspen Generic Sales Forecast 2016-2026
8.8.3 Aspen: Recent Developments
8.8.4 Future Outlook for Aspen’s Generic Business
8.9 Fresenius Kabi
8.9.1 Fresenius Kabi: Historical Financial and Performance Analysis, 2010-2014
8.9.2 Fresenius Kabi Generic Drugs Sales Forecast 2016-2026
8.9.3 InnoPharma Licensing Deal Bolsters Portfolio Grown Via Past Acquisitions
8.9.4 Fresenius Kabi’s Joint Venture with PT Soho Global Health
8.9.5 Future Prospects for Fresenius Kabi’s Generics Business
8.10 Sanofi
8.10.1 Sanofi: Historical Financial and Performance Analysis, 2010-2014
8.10.2 Sanofi Generic Sales Forecast 2016-2026
8.10.3 Sanofi’s Response to Lantus Competition
8.10.4 Sanofi’s Strategies to Develop Generic Sales
8.10.5 Future Prospects for Sanofi’s Generics Business
9. Qualitative Analysis of the Generic Drugs Market, 2016-2026
9.1 Market Factors Influencing the Global Generic Drugs Market
9.2 SWOT Analysis of the Global Generic Drugs Market, 2016-2026
9.2.1 Strengths
9.2.2 Weaknesses
9.2.3 Opportunities
9.2.4 Threats
9.3 Porter’s Five Force Analysis of the Global Generic Drugs Market, 2016-2026
9.3.1 Power of Buyers: Medium
9.3.2 Power of Suppliers: Low
9.3.3 Rivalry among Competitors: High
9.3.4 Threat of New Entrants: High
9.3.5 Threat of Substitutes: Low
10. Conclusions
10.1 Overview of Current Market Conditions and Market Forecast, 2016-2026
10.2 Generic Drugs as a Strategic Tool in Healthcare
10.3 Major Drivers of Growth for Generic Drugs, 2016-2026
10.4 The Regulatory Landscape for Generic Drugs
10.5 Leading Generic Drug Manufacturers
10.6 Future Outlook for the Leading Regions within the Global Generic Drugs Market, 2016-2026
10.7 Generic Penetration by Volume in Leading National Markets
10.8 What Does The Future Hold For The Global Generic Drugs Market?
11. Glossary
【レポート販売概要】
■ タイトル:ジェネリック医薬品の世界市場予測2016-2026■ 英文:Generic Drugs Market Forecast 2016-2026
■ 発行日:2016年4月
■ 調査会社:visiongain
■ 商品コード:VGAIN60631
■ 調査対象地域:グローバル
- 世界の兵士近代化市場(2014-2024):競争環境、戦略的インサイトSynopsis This report shows the leading Soldier Modernization market segments in various regions across the world. Details of top companies active across the global Soldier Modernization market are provided, together with market size and forecast 2014-2024 for the main players across those areas. Summary The report provides a detailed analysis of the competitive landscape of the Soldier Modernizati …
- ハイブリッド・電気自動車用統合ドライブユニットの世界市場2018-2022About Hybrid and Electric Vehicle Integrated Drive Unit Integrated drive unit consists of an electric motor, power electronics, and gearbox packed into a single unit for EVs. Technavio’s analysts forecast the global hybrid and electric vehicle integrated drive unit market will post a revenue of more than USD 4 billion in terms of units by 2022. Covered in this report The report covers the present …
- 世界の患者モニタリングデバイス/装置/システム市場動向(~2018)Attributed to the Rising Prevalence of Neuro-degenerative Diseases, the Patient Monitoring Market in the Neuromonitoring Segment Will Be the Fastest Growing Segment in the Next Five Years The patient monitoring devices form an indispensible part of medical team for every procedure, whether operating in a small clinic or a large multi-specialty hospital. Advanced technology has reduced the size of …
- 高級家具の世界市場分析:材料別(木材、金属、ガラス、皮革、プラスチック)、エンドユーザー別(リビングルーム、ベッドルーム、キッチン、アウトドア、バスルーム、ホスピタリティ、オフィス)、セグメント予測Global luxury furniture market is expected to reach USD 28,600.7 million by 2022 growing at an estimated CAGR of 3.7% from 2015 to 2022, according to a new study by Grand View Research, Inc. This expected growth in demand can be ascribed to rapid urbanization and growing demand for home furnishings. Additionally, disposable income of individuals in North America and Asia-Pacific region has also wi …
- エナジードリンクの世界市場:種類別(アルコール、非アルコール)、エンドユーザー別(子供、大人、青少年)The global energy drinks market size was valued at $53.01 billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01 billion by 2026. Energy drinks are beverages that contain caffeine, taurine, vitamins, and other stimulants, and are marketed as products that boost mental alertness and physical stamina. These drinks may or may not be carbonated. They differ from sports drink, whic …
- 自動車クランクシャフトの世界市場2016-2020About Automotive Crankshaft Internal combustion engines (ICEs) are commonly used in automobiles. Such engines burn a mixture of fuel and air to generate energy, which generates a rotational motion that is transmitted to the vehicle’s wheels. During the process of combustion, the fuel mixture is supplied to the cylinder through an intake valve and post-combustion, the excess emissions are ejected i …
- 簡便(on-the-go)包装の世界市場2016-2020About On-The-Go Packaging On-the-go packaging is used for the packaging of consumer goods in industries such as food and beverages, healthcare, cosmetics, household products, and FMCG used in daily life. Most of the products like food products, beverages, and drugs/medicines are meant for quick consumption, with the packaging offering convenience features such as easy opening, reclosability, porta …
- Fatty Liver Disease:グローバル臨床試験レビューH2, 2013Fatty Liver Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H2, 2013" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recru …
- ウィルソン病治療薬の世界市場2019-2023129 pages, October 2018 About this market The increase in strategic alliances to help market grow. Pharmaceutical companies are engaging in strategic alliances for the development of medications for the treatment of Wilson’s disease. These alliances enhance the R&D activities for new drugs for the treatment of Wilson’s disease. Technavio’s analysts have predicted that the Wilson’s disease drugs ma …
- ピコ・プロジェクターの世界市場2015-2019About Pico Projector A projector is a portable optical device that projects images on any surface or screen. Traditional projector and pico projector are the two types of projector available; the latter is preferred over the former for its small size, light weight, and easy portability. There are two types of pico projector available in the market: standalone and embedded. Technavio's analysts for …
- オフショア石油・ガス向けサイズモ系及び収集の世界市場2016-2020About Offshore Oil and Gas Seismic Equipment and Acquisitions Seismic systems are primary equipment used by oil and gas companies for exploration. These systems are used to create a shock wave on the surface of the ground along a predetermined path to conduct preliminary survey. During the survey, the seismic waves indicate the geological nature of the area and the possibility of oil or gas reserv …
- Prezista (HIV):市場予測と分析(~2022)Prezista (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Prezista (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a d …
- セラミックタイルの世界市場:製品別(床、壁面、天井、屋根)、用途別(改修、商業施設、新築、工業施設)、地域別予測Global Ceramic tiles Market to reach USD 212.6 billion by 2025. Global Ceramic tiles Market valued approximately USD 90.9 billion in 2016 is anticipated to grow with a healthy growth rate of more than 9.90% over the forecast period 2017-2025. Residential replacement, commercial, and new residential are the major application segments of the ceramic tiles market. The residential replacement segment …
- 免疫組織化学の世界市場予測(~2021):抗体、試薬、キット、スライド染色装置、組織マイクロアレイThe immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing …
- Cross Border Resources, Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Cross Border Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Cross Border Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …